Abstract:Objective To investigate the application value of susceptibility weighted imaging (SWI) combined with platelet distribution width (PDW) in intravenous thrombolysis for treatment of patients with acute cerebral infarction (ACI). Methods One hundred and ten patients with ACI treated by intravenous thrombolysis admitted to the Department of Radiology of the Second Affiliated Hospital of Medical College of Zhejiang University from February 2017 to June 2018 were enrolled as the subjects. Before treatment, all patients were detected by routine magnetic resonance imaging (MRI), SWI scanning and PDW detection. The patients were divided into hemorrhage group (77 cases) and non-hemorrhage group (33 cases) according to the presence or absence of hemorrhage shown in SWI, and according to the amount of bleeding, the hemorrhage group patients were subdivided into light (24 cases), medium (32 cases) and severe (21 cases) three groups. After intravenous thrombolysis, the patients were scanned by SWI to show whether bleeding being present or not, the cerebral microbleeding (CMBs) after 24 hours treatment in two groups, and after treatment of 14 days, modified Rankin score (MRS), PDW and hemorrhagic transformation (HT) situation in the two groups were evaluated and compared, the differences in hemorrhagic infarction 1 (HI1), hemorrhagic infarction 2 (HI2), parenchymal hemorrhage 1 (PH1) and parenchymal hemorrhage 2 (PH2) in different bleeding volume groups were compared. Results Before treatment, 129 lesions detected by SWI were significantly greater than 14 lesions detected by T1 weighted imaging, 22 lesions detected by T2 weighted imaging and 86 lesions detected by diffusion weighted imaging. After treatment for 24 hours, the number of CMBs (number: 10 vs. 0), after treatment for 14 days, the incidence of HT [36.36% (28/77) vs. 12.12% (4/33)], MRS (1.78±0.39 vs. 1.51±0.42) and PDW [(12.34±5.29)% vs. (6.79±3.27)%] in the hemorrhagic group were higher than those in non-hemorrhagic group (all P < 0.05). After treatment of 14 days, the incidences of HT [71.43% (15/21) vs. 20.83% (5/24), 25.00% (8/32)], PDW [(14.52±4.11)% vs. (10.78±3.67)%, (11.34±3.89)%] in severe group were higher than those in light group and moderate groups (all P < 0.05), and the rate of good prognosis was significantly lower than those in mild and moderate groups [42.86% (9/21) vs. 70.83% (17/24), 71.88% (23/32), P < 0.05]. The incidence of HT in severe group was also significantly higher than those in the non-hemorrhage group [71.43% (15/21) vs. 11.76% (4/34), P < 0.05]. Conclusion SWI combined with PDW can guide the intravenous thrombolysis very well for patients with ACI, and has relatively high clinical value.

Value of susceptibility weighted imaging in diagnosis of cerebral hemorrhage due to amyloid cerebrovascular disease

Association Between Remote Diffusion-Weighted Imaging Lesions and Cerebral Small Vessel Disease in Primary Intracerebral Hemorrhage

A study on application value of susceptibility weighted imaging combined with platelet distribution width in intravenous thrombolysis for treatment of patients with acute cerebral infarction

Detection of Cerebral Microbleeding by Susceptibility Weighted Imaging Sequence and Research on Relation Between CMBs and Risk Factors

Evaluation of cerebral haemorrhage SWI in by at 3.0 T MRI

Cerebral Microbleeds: Burden Assessment by Using Quantitative Susceptibility Mapping

Susceptibility-diffusion mismatch predicts thrombolytic outcomes: a retrospective cohort study.

Correlation study and clinical value analysis between cerebral microbleeds and white matter hyperintensity with high-field susceptibility-weighted imaging

Value of Multiple Sequences at 3.0T Magnetic Resonance Imaging for Diagnosis of Cerebral Microbleeds

Relationship of cerebral microbleeds and cognitive impairment in seniors revealed by susceptibility weighted imaging

Clinical Application Evaluation of Conventional Gradient-echo Imaging in Micro-intracranial Hemorrhage

Clinical Application of Susceptibility Weighted Imaging in Brain Tumors

Susceptibility-weighted imaging in grading brain astrocytomas

The accuracy of SWI sequences to detect acute MCA occlusion

[Cerebral Lesions of DWI Hyperintensity in Patients with Subacute Stroke Assessed by Intravoxel Incoherent Motion Technique].

Susceptibility Weighted Imaging in the Evaluation of Hemorrhagic Diffuse Axonal Injury.

Value of MR susceptibility weighted angiography (SWAN)imaging in the diagnosis of brain diseases in children

Improved Sensitivity of 3.0 Tesla Susceptibility-Weighted Imaging in Detecting Traumatic Bleeds and Its Use in Predicting Outcomes in Patients with Mild Traumatic Brain Injury.

Quantitative comparison of CSVD imaging markers between patients with possible amyloid small vessel disease and with non-amyloid small vessel disease

Susceptibility-weighted imaging: The value in cerebral astrocytomas grading

Application of SWI and DWI in Evaluating the Vulnerability of Carotid Plaque